IGMPI facebook News
IGMPI Logo
Faculty of Pharmaceutical Sciences

(An Autonomous Body Recognized by Ministry of Commerce & Industry, Government of India)

ADMISSIONS NOTICE
18001031071 (Toll Free), +91 11 26512850
Regular Classroom | Online Mode
HERCULES phase 3 study of tolebrutinib to treat non-relapsing secondary progressive MS meets key primary endpoint : Sanofi
Emergency Use Authorization to Novavax 2024-2025 Formula Covid-19 vaccine to prevent Covid-19 in individuals aged 12 and older: US FDA
VitusCare motivates female patients to undergo regular dialysis on the occasion of Women?s Equality Day
Qiagen expands collaboration with AstraZeneca to develop and commercialize companion diagnostics, QIAstat-Dx
European Commission authorises expanded age indication for GSK?s Arexvy: The first respiratory syncytial virus vaccine for adults aged 50-59 at increased risk
Ultromics?s EchoGo did not meet primary endpoint in heart disease trial
Roche to showcase positive phase II FENopta OLE study data of BTK inhibitor, fenebrutinib for treating relapsing MS at 40th Congress of ECTRIMS
The Cuddles Foundation?s FoodHeals report reveals -Over half of India?s childhood cancer patients require nutritional support in their cancer battle,
CurifyLabs and APL collaborate to support critically ill patients with 3D printing medicine technology
Apple obtains FDA nod for hearing aid software for selected Airpods
Roche to launch new CGM in Europe
FDA to investigate metals' presence in tampons
Smiths Medical associates 1 death, 35 injuries to defective airway tubes
Many FDA-approved AI devices lack validation data
UK recognized a toxic firefighting foam threat in 2003 but delayed regulation